Personal information

Activities

Collapse all

Works (5)

Identifying novel mechanisms of biallelic TP53 loss refines poor outcome for patients with multiple myeloma

Blood Cancer Journal
2023-09-11 | Journal article
DOI: 10.1038/s41408-023-00919-2
Contributors: Enze Liu; Parvathi Sudha; Nathan Becker; Oumaima Jaouadi; Attaya Suvannasankha; Kelvin Lee; Rafat Abonour; Mohammad Abu Zaid; Brian A. Walker
Source: check_circle
Crossref

Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study

Journal of Clinical Oncology
2023-04-01 | Journal article
DOI: 10.1200/JCO.22.00958
Contributors: Carrie L. Kitko; Mukta Arora; Zachariah DeFilipp; Mohammad Abu Zaid; Antonio Di Stasi; Vedran Radojcic; Courtney B. Betts; Lisa M. Coussens; Michael L. Meyers; Hope Qamoos et al.
Source: check_circle
Crossref

Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study

Journal of Clinical Oncology
2023-04-01 | Journal article
DOI: 10.1200/JCO.22.00509
Contributors: David Bernard Miklos; Mohammad Abu Zaid; Julian P. Cooney; Jörn C. Albring; Mary Flowers; Alan P. Skarbnik; Ibrahim Yakoub-Agha; Bor-Sheng Ko; Benedetto Bruno; Edmund K. Waller et al.
Source: check_circle
Crossref

Effect of Sirolimus levels between days 11 and 20 after allogeneic stem cell transplantation on the risk of hepatic sinusoidal obstruction syndrome

Bone Marrow Transplantation
2021-01-04 | Journal article
DOI: 10.1038/s41409-020-0987-1
Contributors: Vaibhav Agrawal; Praveen Ranganath; Kirsten D. Ervin; Caitlin A. Schmidt; Elizabeth A. Cox; Robert P. Nelson, Jr.; Jennifer E. Schwartz; Mohammad Abu Zaid; Rafat Abonour; Michael J. Robertson et al.
Source: check_circle
Crossref

CXCL10: most consistent cGVHD biomarker?

Blood
2016-06-16 | Journal article
DOI: 10.1182/blood-2016-04-709543
Contributors: Sophie Paczesny; Mohammad Abu Zaid
Source: check_circle
Crossref
How many people are using ORCID?